Malignant mesothelioma in situ
- 26 February 2018
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 72 (6), 1033-1038
- https://doi.org/10.1111/his.13468
Abstract
The existence of malignant mesothelioma in situ (MIS) is often postulated, but there are no accepted morphologic criteria for making such a diagnosis. Here we report two cases that appear to be true MIS on the basis of in situ genomic analysis. In one case the patient had repeated unexplained pleural unilateral effusions. Two thoracoscopies 9 months apart revealed only visually normal pleura. Biopsies from both thoracoscopies showed only a single layer of mildly reactive mesothelial cells. However, these cells had lost BAP1 and showed loss of CDKN2A (“p16″) by FISH. NF2 was not deleted by FISH but 28% of the mesothelial cells showed hyperploidy. Six months after the second biopsy the patient has persisting effusions but no evidence of pleural malignancy on imaging. The second patient presented with ascites and minimal omental thickening on imaging, but no visual evidence of tumor at laparoscopy. Omental biopsy showed a single layer of minimally atypical mesothelial cells with rare tiny foci of superficial invasion of fat. BAP1 immunostain showed loss of nuclear BAP1 in all of the surface mesothelial cells and the invasive cells. There was CDKN2A deletion but no deletion of NF2 by FISH. These cases show that morphologically bland single-layered surface mesothelial proliferations with molecular alterations previously seen only in invasive malignant mesotheliomas do exist, and presumably represent malignant mesothelioma in situ. More cases are need to understand the frequency of such changes and the time course over which invasive tumor develops.Keywords
This publication has 15 references indexed in Scilit:
- New Markers for Separating Benign From Malignant Mesothelial Proliferations Are We There Yet?Archives Of Pathology & Laboratory Medicine, 2016
- The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesotheliomaLaboratory Investigation, 2016
- NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK InhibitionCancer Discovery, 2015
- p16 FISH Deletion in Surface Epithelial Mesothelial Proliferations Is Predictive of Underlying Invasive MesotheliomaThe American Journal of Surgical Pathology, 2014
- Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkersJournal of Clinical Pathology, 2013
- The Separation of Benign and Malignant Mesothelial ProliferationsArchives Of Pathology & Laboratory Medicine, 2012
- Prominent In Situ Component in a Pleural Malignant MesotheliomaInternational Journal of Surgical Pathology, 2010
- Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomasLaboratory Investigation, 2008
- Chromosomal alterations in early stages of malignant mesotheliomasVirchows Archiv, 2005
- Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/ArfOncogene, 2004